Financial Health Assessment: APEM COMPONENTS LIMITED

1. Financial Health Score: A-

Explanation: APEM Components Limited presents the financial profile of a robust, well-capitalised business with healthy vital signs. The company operates with no bank borrowings, has strengthened its balance sheet significantly year-over-year, and maintains profitable operations despite challenging external conditions. The slight deduction from a full A grade reflects margin pressures from commodity prices and exchange rates, alongside static revenue growth in 2019 and the ongoing uncertainties created by the global pandemic.

2. Key Vital Signs

Heart Rate – Profitability

Interpretation: The patient's heart is beating strongly. Profitability has improved by nearly 10%, and the return on assets has improved, indicating the business is generating more profit from its asset base. The slight dip in return on equity is simply a mathematical consequence of retained profits swelling the equity base – not a symptom of deteriorating performance.

Blood Pressure – Liquidity & Cash Flow

Interpretation: Healthy cash flow with no signs of hypertension. Cash reserves have grown by nearly a third, while total liabilities have been reduced by over £1.18 million. The company explicitly states it has no bank borrowings or finance, operating entirely within its own cash reserves. This is the financial equivalent of excellent blood pressure – the business is not straining to meet its obligations.

Cholesterol – Debt-to-Equity Ratio

Interpretation: Significantly improved. The company has substantially reduced its reliance on liabilities relative to equity. A ratio below 50% is generally considered healthy for a manufacturing business, and APEM has moved firmly into this territory. The "cholesterol" is clearing from the system.

Bone Density – Capital Structure & Retained Earnings

Interpretation: Exceptionally strong bone density. The company has built approximately £10.2 million in retained earnings on just £100,000 of share capital. This represents over 40 years of consistent profit reinvestment since incorporation in 1983. The decision to pay no dividends suggests a deliberate strategy of retaining earnings for growth and resilience – the business is building its financial immune system rather than distributing wealth.

BMI – Asset Efficiency

Interpretation: Total assets remained essentially flat, meaning the profit improvement came from operational efficiency and liability reduction rather than asset expansion. This is not concerning given the static business growth mentioned in the strategic report, but does suggest the business could potentially do more with its asset base.

3. Diagnosis

Overall Financial Condition: Healthy with Monitored Conditions

The financial data reveals a business in robust financial health, displaying several positive indicators:

Strengths: - Debt-free operation – The company carries no bank borrowings, eliminating interest expense burden and providing maximum financial flexibility - Strong profit growth – 9.7% increase in after-tax profit demonstrates operational resilience - Significant liability reduction – £1.18 million of liabilities paid down, strengthening the balance sheet - Growing cash reserves – 31.2% increase in cash provides a healthy buffer against uncertainty - Consistent profit retention – Over £10 million in accumulated retained earnings provides substantial financial cushion - Going concern status confirmed – Directors have assessed the company as a going concern with confidence in the next 12 months and beyond

Symptoms Requiring Monitoring: - Static revenue growth – The strategic report acknowledges "business growth was static over the course of 2019," suggesting the top line is under pressure - Margin compression – Rising commodity prices and sustained weak pound are weighing on profitability; the company is offsetting this through operational improvements, but this requires ongoing effort - Exchange rate vulnerability – Buying and selling in Euros and US Dollars creates ongoing translation and transaction risk - COVID-19 uncertainty – While the company has traded throughout the pandemic as a critical supplier, the longer-term economic impact remains uncertain - Group dependency – Over 75% ownership by Contact Technologies UK Limited means strategic decisions are made at group level; the company's financial autonomy is limited

Underlying Business Health Assessment: The company operates in a specialised manufacturing niche (human-machine interface components) with products serving medical, logistical, and industrial applications. This positioning has proven resilient during the pandemic, with the company designated as supplying "critically important" equipment. The 37-year trading history and accumulated profits suggest a sustainable business model with competitive advantages in its sector.

4. Prognosis

Future Financial Outlook: Cautiously Positive

Short-term (12 months): The company is well-positioned to weather ongoing uncertainty. With no debt, growing cash reserves, and £10.3 million in net assets, the financial "immune system" is strong. The critical supplier status during COVID-19 provides some revenue protection. However, the economic fallout from the pandemic may suppress demand in certain sectors.

Medium-term (1-3 years): The strategic report references new product roadmaps, IDEC product distribution agreements, and growth in machine automation trends. If the company can translate these opportunities into revenue growth while maintaining its cost discipline, the financial trajectory should continue upward. The transition away from Brexit uncertainty (which weighed heavily on 2019) may provide some relief.

Risk Factors: The primary risks to this prognosis are: 1. Prolonged economic downturn reducing demand for capital equipment 2. Further sterling weakness increasing input costs 3. Supply chain disruption affecting manufacturing capability 4. Group-level decisions that may not align with the UK entity's best interests

5. Recommendations

Prescribed Course of Action

1. Revenue Growth Therapy – The static revenue growth in 2019 is the most notable symptom requiring attention. Consider: - Accelerating new product launches mentioned in the strategic report - Exploiting the IDEC product distribution opportunity more aggressively - Targeting sectors showing resilience through economic disruption (medical, logistics, automation)

2. Margin Protection Regimen – With commodity price and exchange rate pressures ongoing: - Continue hedging strategies for currency exposure - Pursue procurement efficiencies to offset input cost increases - Maintain pricing discipline with key accounts

3. Cash Management Optimisation – While £956,851 in cash is healthy, consider: - Whether surplus cash could be deployed more productively in growth investments - Short-term deposit strategies to maximise returns on idle cash - Working capital optimisation to free up additional cash for strategic initiatives

4. Dividend Policy Review – With no dividends paid and substantial retained earnings: - Evaluate whether returning some capital to the parent company (Contact Technologies UK Limited) might be appropriate - Balance the desire for financial resilience against the opportunity cost of holding excess capital

5. Strategic Investment – The strong balance sheet provides capacity for: - Capital expenditure in manufacturing efficiency - Potential acquisitions aligned with growth strategy - R&D investment in emerging HMI technologies

6. Risk Monitoring – Continue active management of: - Currency exposure across Euro and Dollar transactions - Supply chain resilience for critical components - Customer credit risk in an uncertain economic environment